Canada · Delayed Price · Currency is CAD MedMira Statistics
Total Valuation
MedMira has a market cap or net worth of CAD 52.63 million. The enterprise value is 68.81 million.
| Market Cap | 52.63M |
| Enterprise Value | 68.81M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MedMira has 701.73 million shares outstanding. The number of shares has increased by 13.35% in one year.
| Current Share Class | 701.73M |
| Shares Outstanding | 701.73M |
| Shares Change (YoY) | +13.35% |
| Shares Change (QoQ) | +29.83% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | n/a |
| Float | 209.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 218.83 |
| PB Ratio | -2.33 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.21 |
| EV / Sales | 286.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -21.82 |
Financial Position
The company has a current ratio of 0.07
| Current Ratio | 0.07 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.31 |
| Interest Coverage | -3.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -46.02% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 19.58% |
| Revenue Per Employee | 4,625 |
| Profits Per Employee | -87,008 |
| Employee Count | 52 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 4.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.25% in the last 52 weeks. The beta is 0.57, so MedMira's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -6.25% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 48.07 |
| Average Volume (20 Days) | 89,804 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedMira had revenue of CAD 240,509 and -4.52 million in losses. Loss per share was -0.01.
| Revenue | 240,509 |
| Gross Profit | -672,696 |
| Operating Income | -3.59M |
| Pretax Income | -4.52M |
| Net Income | -4.52M |
| EBITDA | -3.27M |
| EBIT | -3.59M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 14,910 in cash and 16.75 million in debt, giving a net cash position of -16.73 million or -0.02 per share.
| Cash & Cash Equivalents | 14,910 |
| Total Debt | 16.75M |
| Net Cash | -16.73M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -22.56M |
| Book Value Per Share | -0.02 |
| Working Capital | -20.42M |
Cash Flow
In the last 12 months, operating cash flow was -3.15 million and capital expenditures -7,468, giving a free cash flow of -3.15 million.
| Operating Cash Flow | -3.15M |
| Capital Expenditures | -7,468 |
| Free Cash Flow | -3.15M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | -279.70% |
| Operating Margin | -1,492.56% |
| Pretax Margin | -1,881.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedMira does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.35% |
| Shareholder Yield | -13.35% |
| Earnings Yield | -8.60% |
| FCF Yield | -5.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |